Pharma Foods International Co (TSE:2929) Current Deferred Revenue: 円0 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2929 Pharma Foods International Co Ltd TSE:2929
69 GF Score
Price 円618.00
GF Value 円1,050.11
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Pharma Foods International Co Current Deferred Revenue?

Pharma Foods International Co TSE:2929 69 Current Deferred Revenue is 円0 Mil as of Jan. 2026. GuruFocus rates TSE:2929 with a GF Score™ of 69/100 and a GF Value™ of 円1,050.11 (Possible Value Trap). The stock has 5 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Pharma Foods International Co's current deferred revenue for the quarter that ended in Jan. 2026 was 円0 Mil.

Pharma Foods International Co Current Deferred Revenue Related Terms

Pharma Foods International Co Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Pharma Foods International Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Foods International Co Current Deferred Revenue Chart

Pharma Foods International Co Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Pharma Foods International Co Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Jul25 Oct25 Jan26 Apr26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:2929
69GF Score
Pharma Foods International Co Ltd TSE:2929
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of 円0 Mil mean?
Pharma Foods International Co (TSE:2929) has a Current Deferred Revenue of 円0 Mil as of Jan. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Pharma Foods International Co and its competitors.
Is Pharma Foods International Co's Current Deferred Revenue too high?
Pharma Foods International Co's current Current Deferred Revenue is 円0 Mil. Overall, Pharma Foods International Co has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pharma Foods International Co's Current Deferred Revenue compare to ZTS?
Pharma Foods International Co's Current Deferred Revenue of 円0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Drug Manufacturers company?
A good Current Deferred Revenue depends on the Drug Manufacturers industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Pharma Foods International Co and its competitors. Pharma Foods International Co's current Current Deferred Revenue is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Foods International Co stock overvalued right now?
Based on GuruFocus' analysis, Pharma Foods International Co (TSE:2929) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,050.11, compared to a current price of 円618.00 — trading 41.1% below its estimated fair value. The current Current Deferred Revenue is 円0 Mil. Pharma Foods International Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Pharma Foods International Co (TSE:2929), the current Current Deferred Revenue is 円0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Foods International Co (TSE:2929) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Foods International Co stock appears to be undervalued. The current stock price of 円618.00 is trading 41.1% below its estimated GF Value™ of 円1,050.11. GuruFocus considers Pharma Foods International Co to be Possible Value Trap.

Key valuation signals for TSE:2929:

  • Current Deferred Revenue: 円0 Mil
  • GF Value™: 円1,050.11 vs. price of 円618.00 (41.1% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the TSE:2929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Foods International Co Business Description

Address 1-49 Ohara Kyoto imperial tomb Saikyo-ku, Kyoto, JPN, 615-8245
Pharma Foods International Co Ltd is engaged in the development and sales of functional food materials.
69GF Score

Get the complete analysis for TSE:2929

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円618.00
Price
円1,050.11
GF Value